100-63-0 |
phenyl hydrazine |
hydrazine, phenyl-; Phenylhydrazine; hydrazine; phenylhydrazine hydrochloride (1:1); phenylhydrazine sulfate |
C6H10N2 |
11
supplier(s) 100-63-0 |
120511-73-1 |
Anastrozole |
ICI-D-1033;ARIMIDEX;1-[3,5-DI-(1-METHYL-1-CYANO)-ETHYL]-BENZYL-1,2,4-TRIAZOLE;ANASTRAZOLE;ANASTROZOLE;tetramethyl-5-(1h-1,2,4-triazol-1ylmethyl) 1,3-benzenediacetionitrile;ZD-1033;1,3-benzenediacetonitrile,alpha,alpha,alpha’,alpha’-tetramethyl-5-(1h-1,2,4-t |
C17H19N5 |
16
supplier(s) 120511-73-1 |
125317-39-7 |
Vinorelbine Ditartrate |
Vinorelbine bitartrate; 3',4'-didehydro-4'-deoxy-c'-norvincaleukoblastine R-(R*,R*)-2-3-dihydroxybutanedioate (1:2) salt; Navelbine tartrate; Nvb; Navelbine; Vinorelbin; Bitartrate; Vinorelbine ditartaric acid; Vinorelbine ditartrate salt; Butanedioate(1:2); C'-norvincaleukoblastine,3',4'-didehydro-4'-dioxy-,(R-(R*,R*))-2,3-dihydroxy; 5'-noranhydrovinoblastine tartrate; 3',4'-didehydro-4'-deoxy-c'-norvincaleukoblastine; [R-(R*,R*)-2-3-dihydroxybutanedioate (1:2) salt]; Pacilitaxel; Vinorelbineditartrate salt hydrate; Vinorelbine tartrate usp standard; Vinorelbine tartrate; Vinorelbine bitratrate; Vinorelbine tartarate; methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate 2,3-dihydroxybutanedioate (1:2); methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate 2,3-dihydroxybutanedioate (1:2); methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-15-[(6R,8S)-4-ethyl-8-(methoxycarbonyl)-1,3,6,7,8,9-hexahydro-2,6-methanoazecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate |
C45H54N4O8 |
7
supplier(s) 125317-39-7 |
130209-82-4 |
Latanoprost |
XALATAN; ISOPROPYL (5Z, 9A,11A,15R)-9,11,15-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROST-5Z-EN-1-OATE; 17-PHENYL-13,14-DIHYDRO TRINOR PROSTAGLANDIN F2ALPHA ISOPROPYL ESTER; 9ALPHA,11ALPHA,15R-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROST-5Z-EN-1-OIC ACID, ISOPROPYL ESTER; 9ALPHA, 11ALPHA, 15S-TRIHYDROXY-17-PHENYL-18,19,20-TRINOR-PROS-5Z-EN-1-OIC ACID, ISOPROPYL ESTER; (1r-(1-alpha(z),2-beta(r*),3-alpha,5-alpha))--methylethyleste; 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl)-5-heptenoicaci1; propan-2-yl.7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-pentyl)-cyclopentyl]hept-5-enoate; 1-methylethyl (5E)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate; 1-methylethyl (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl}hept-5-enoate; propan-2-yl (5E)-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]hept-5-enoate |
C26H40O5 |
17
supplier(s) 130209-82-4 |
100-83-4 |
3-Hydroxybenzaldehyde |
3-Hydroxydenzaldehyde; 3-hydroxy benzaldehyde; m-hydroxy benzaldehyde; m-Hydroxybenzaldehyde; 4-hydroxy-3-(3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl)benzoic acid |
C7H6O2 |
5
supplier(s) 100-83-4 |
153-18-4 |
Rutin |
C.I. 75730; Rutin [JAN]; (+)-Rutin Hydrate; Quercetin-3-rutinoside~Vitamin P; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-O-(6-deoxyhexopyranosyl)hexopyranoside; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-D-glucopyranoside |
C27H30O16 |
35
supplier(s) 153-18-4 |
1405-20-5 |
polymyxin B standard solution |
polymyxin B sulfate usp; Polymyxin B sulfate salt; Polymyxin B Sulphate; Polymyxin B solution; Polymyxin B sulfate; Polymyxin B 2,5-SULFATE; Polymyxin B (PMB); N-[3-amino-1-[[1-[[3-amino-1-[[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(1-hydroxyethyl)-12-isobutyl-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]carbamoyl]propyl]carbamoyl]-2-hydroxy-propyl]carbamoyl]propyl]-6-methyl-octanamide; sulfuric acid; N~2~-[4-amino-2-(formylamino)butanoyl]-N-(3-amino-1-{[6,9,18-tris(2-aminoethyl)-15-benzyl-3-(2-hydroxyethyl)-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclotricosan-21-yl]carbamoyl}propyl)homoserinamide sulfate (salt) |
C48H84N16O17S |
15
supplier(s) 1405-20-5 |
16310-20-6 |
SEROTONIN O-SULFATE |
SEROTONIN O-SULFATE;5-HYDROXYTRYPTAMINE O-SULFATE;Serotonium o-sulfate;1H-Indol-5-ol, 3-(2-aminoethyl)-, hydrogen sulfate (ester);2906-14-1 (Sulfate) |
C10H12N2O4S |
8
supplier(s) 16310-20-6 |
104987-11-3 |
Tacrolimus |
Tacarolimus; 3-(2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl)-14,16-dimethoxy-9,10,12,; (3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone; (3S,4R,5S,8R,12S,14S,15R,16S,18R,19R,26aS)-5,19-dihydroxy-3-{(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl}-14,16-dimethoxy-4,10,12,18-tetramethyl-8-prop-2-en-1-yl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1,4]oxazacyclotricosine-1,7,20,21(4H,23H)-tetrone |
C44H69NO12 |
22
supplier(s) 104987-11-3 |
104010-37-9 |
Sodium Ceftiofur |
naxcel; u-64279e; ceftiofur sodium salt; Ceftiofur sodium; sodium 7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(furan-2-ylcarbonyl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; sodium (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-{[(furan-2-ylcarbonyl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate |
C19H16N5NaO7S3 |
14
supplier(s) 104010-37-9 |